New hope for advanced kidney cancer: first human trial of NEO-811 begins

NCT ID NCT07300241

Recruiting now Disease control Sponsor: Neomorph, Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 4 times

Summary

This early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that has spread or cannot be surgically removed. The goal is to find the safest dose and see how well the drug works. About 30 participants who have already tried other treatments or cannot take them will be enrolled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CCRCC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

clear cell renal carcinoma Clear-cell metastatic renal cell carcinoma hereditary clear cell renal cell carcinoma kidney cancer nonpapillary renal cell carcinoma renal cell carcinoma von Hippel-Lindau disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CCRCC CLEAR CELL RENAL CELL CARCINOMA CLEAR CELL RENAL CELL CARCINOMA METASTATIC KIDNEY CANCER METASTATIC KIDNEY CANCERS RCC RENAL CELL CARCINOMA VHL-ASSOCIATED CLEAR CELL RENAL CELL CARCINOMA VHL-ASSOCIATED RENAL CELL CARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

NEO-811 Chicago Site
RECRUITING

Zion, Illinois, 60099, United States
NEO-811 Connecticut Site
RECRUITING

New Haven, Connecticut, 06520, United States
NEO-811 Dallas Site
RECRUITING

Dallas, Texas, 75039, United States
NEO-811 Grand Rapids Site
RECRUITING

Grand Rapids, Michigan, 49503, United States
NEO-811 Houston Site
RECRUITING

Houston, Texas, 77054, United States
NEO-811 Long Island Site
RECRUITING

Lake Success, New York, 11042, United States
NEO-811 Los Angeles Site
RECRUITING

Duarte, California, 91010, United States
NEO-811 NYC Site
RECRUITING

New York, New York, 10065, United States
NEO-811 Omaha Site
RECRUITING

Omaha, Nebraska, 68130, United States
NEO-811 San Diego Site
RECRUITING

San Diego, California, 92037, United States
NEO-811 South Carolina Site
RECRUITING

Myrtle Beach, South Carolina, 29572, United States
NEO-811 Virginia Site
RECRUITING

Fairfax, Virginia, 22031, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.